Global IVD Infectious Diseases Market Insights, Forecast to 2029

Publisher Name :
Date: 19-Jun-2023
No. of pages: 117
Inquire Before Buying

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

Market Analysis and Insights: Global IVD Infectious Diseases Market

The global IVD Infectious Diseases market is projected to grow from US$ 17780 million in 2023 to US$ 22230 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

The US & Canada market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for IVD Infectious Diseases market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of IVD Infectious Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for IVD Infectious Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IVD Infectious Diseases revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global IVD Infectious Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for IVD Infectious Diseases revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc.

By Company

- BD

- BioMerieux

- Abbott

- Quidel

- Gen-Probe

- Abbott

- Danaher

- Sysmex

- Orasure

- Hologic

- Cepheid

- Qiagen

- Roche Diagnostics

- Siemens Healthcare

- Bio-Rad Laboratories

Segment by Type

- Immunochemistry

- Molecular Diagnostics

Segment by Application

- Clinical Laboratories

- Diagnostic Centers

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of IVD Infectious Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IVD Infectious Diseases companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVD Infectious Diseases revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global IVD Infectious Diseases Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immunochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global IVD Infectious Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Laboratories
1.3.3 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Diseases Market Perspective (2018-2029)
2.2 Global IVD Infectious Diseases Growth Trends by Region
2.2.1 IVD Infectious Diseases Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 IVD Infectious Diseases Historic Market Size by Region (2018-2023)
2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2024-2029)
2.3 IVD Infectious Diseases Market Dynamics
2.3.1 IVD Infectious Diseases Industry Trends
2.3.2 IVD Infectious Diseases Market Drivers
2.3.3 IVD Infectious Diseases Market Challenges
2.3.4 IVD Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue IVD Infectious Diseases by Players
3.1.1 Global IVD Infectious Diseases Revenue by Players (2018-2023)
3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2018-2023)
3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of IVD Infectious Diseases, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global IVD Infectious Diseases Market Concentration Ratio
3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2022
3.5 Global Key Players of IVD Infectious Diseases Head office and Area Served
3.6 Global Key Players of IVD Infectious Diseases, Product and Application
3.7 Global Key Players of IVD Infectious Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Diseases Breakdown Data by Type
4.1 Global IVD Infectious Diseases Historic Market Size by Type (2018-2023)
4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2024-2029)
5 IVD Infectious Diseases Breakdown Data by Application
5.1 Global IVD Infectious Diseases Historic Market Size by Application (2018-2023)
5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America IVD Infectious Diseases Market Size (2018-2029)
6.2 North America IVD Infectious Diseases Market Size by Type
6.2.1 North America IVD Infectious Diseases Market Size by Type (2018-2023)
6.2.2 North America IVD Infectious Diseases Market Size by Type (2024-2029)
6.2.3 North America IVD Infectious Diseases Market Share by Type (2018-2029)
6.3 North America IVD Infectious Diseases Market Size by Application
6.3.1 North America IVD Infectious Diseases Market Size by Application (2018-2023)
6.3.2 North America IVD Infectious Diseases Market Size by Application (2024-2029)
6.3.3 North America IVD Infectious Diseases Market Share by Application (2018-2029)
6.4 North America IVD Infectious Diseases Market Size by Country
6.4.1 North America IVD Infectious Diseases Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America IVD Infectious Diseases Market Size by Country (2018-2023)
6.4.3 North America IVD Infectious Diseases Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe IVD Infectious Diseases Market Size (2018-2029)
7.2 Europe IVD Infectious Diseases Market Size by Type
7.2.1 Europe IVD Infectious Diseases Market Size by Type (2018-2023)
7.2.2 Europe IVD Infectious Diseases Market Size by Type (2024-2029)
7.2.3 Europe IVD Infectious Diseases Market Share by Type (2018-2029)
7.3 Europe IVD Infectious Diseases Market Size by Application
7.3.1 Europe IVD Infectious Diseases Market Size by Application (2018-2023)
7.3.2 Europe IVD Infectious Diseases Market Size by Application (2024-2029)
7.3.3 Europe IVD Infectious Diseases Market Share by Application (2018-2029)
7.4 Europe IVD Infectious Diseases Market Size by Country
7.4.1 Europe IVD Infectious Diseases Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe IVD Infectious Diseases Market Size by Country (2018-2023)
7.4.3 Europe IVD Infectious Diseases Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China IVD Infectious Diseases Market Size (2018-2029)
8.2 China IVD Infectious Diseases Market Size by Type
8.2.1 China IVD Infectious Diseases Market Size by Type (2018-2023)
8.2.2 China IVD Infectious Diseases Market Size by Type (2024-2029)
8.2.3 China IVD Infectious Diseases Market Share by Type (2018-2029)
8.3 China IVD Infectious Diseases Market Size by Application
8.3.1 China IVD Infectious Diseases Market Size by Application (2018-2023)
8.3.2 China IVD Infectious Diseases Market Size by Application (2024-2029)
8.3.3 China IVD Infectious Diseases Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia IVD Infectious Diseases Market Size (2018-2029)
9.2 Asia IVD Infectious Diseases Market Size by Type
9.2.1 Asia IVD Infectious Diseases Market Size by Type (2018-2023)
9.2.2 Asia IVD Infectious Diseases Market Size by Type (2024-2029)
9.2.3 Asia IVD Infectious Diseases Market Share by Type (2018-2029)
9.3 Asia IVD Infectious Diseases Market Size by Application
9.3.1 Asia IVD Infectious Diseases Market Size by Application (2018-2023)
9.3.2 Asia IVD Infectious Diseases Market Size by Application (2024-2029)
9.3.3 Asia IVD Infectious Diseases Market Share by Application (2018-2029)
9.4 Asia IVD Infectious Diseases Market Size by Region
9.4.1 Asia IVD Infectious Diseases Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia IVD Infectious Diseases Market Size by Region (2018-2023)
9.4.3 Asia IVD Infectious Diseases Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type
10.2.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application
10.3.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country
10.4.1 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD IVD Infectious Diseases Introduction
11.1.4 BD Revenue in IVD Infectious Diseases Business (2018-2023)
11.1.5 BD Recent Developments
11.2 BioMerieux
11.2.1 BioMerieux Company Details
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux IVD Infectious Diseases Introduction
11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2018-2023)
11.2.5 BioMerieux Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott IVD Infectious Diseases Introduction
11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2018-2023)
11.3.5 Abbott Recent Developments
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel IVD Infectious Diseases Introduction
11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2018-2023)
11.4.5 Quidel Recent Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Details
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe IVD Infectious Diseases Introduction
11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2018-2023)
11.5.5 Gen-Probe Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott IVD Infectious Diseases Introduction
11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2018-2023)
11.6.5 Abbott Recent Developments
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher IVD Infectious Diseases Introduction
11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2018-2023)
11.7.5 Danaher Recent Developments
11.8 Sysmex
11.8.1 Sysmex Company Details
11.8.2 Sysmex Business Overview
11.8.3 Sysmex IVD Infectious Diseases Introduction
11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2018-2023)
11.8.5 Sysmex Recent Developments
11.9 Orasure
11.9.1 Orasure Company Details
11.9.2 Orasure Business Overview
11.9.3 Orasure IVD Infectious Diseases Introduction
11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2018-2023)
11.9.5 Orasure Recent Developments
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic IVD Infectious Diseases Introduction
11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2018-2023)
11.10.5 Hologic Recent Developments
11.11 Cepheid
11.11.1 Cepheid Company Details
11.11.2 Cepheid Business Overview
11.11.3 Cepheid IVD Infectious Diseases Introduction
11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2018-2023)
11.11.5 Cepheid Recent Developments
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen IVD Infectious Diseases Introduction
11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2018-2023)
11.12.5 Qiagen Recent Developments
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Details
11.13.2 Roche Diagnostics Business Overview
11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2018-2023)
11.13.5 Roche Diagnostics Recent Developments
11.14 Siemens Healthcare
11.14.1 Siemens Healthcare Company Details
11.14.2 Siemens Healthcare Business Overview
11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2018-2023)
11.14.5 Siemens Healthcare Recent Developments
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Details
11.15.2 Bio-Rad Laboratories Business Overview
11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2018-2023)
11.15.5 Bio-Rad Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Immunochemistry
Table 3. Key Players of Molecular Diagnostics
Table 4. Global IVD Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global IVD Infectious Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global IVD Infectious Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global IVD Infectious Diseases Market Share by Region (2018-2023)
Table 8. Global IVD Infectious Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global IVD Infectious Diseases Market Share by Region (2024-2029)
Table 10. IVD Infectious Diseases Market Trends
Table 11. IVD Infectious Diseases Market Drivers
Table 12. IVD Infectious Diseases Market Challenges
Table 13. IVD Infectious Diseases Market Restraints
Table 14. Global IVD Infectious Diseases Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global IVD Infectious Diseases Revenue Share by Players (2018-2023)
Table 16. Global Top IVD Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2022)
Table 17. Global IVD Infectious Diseases Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of IVD Infectious Diseases, Headquarters and Area Served
Table 20. Global Key Players of IVD Infectious Diseases, Product and Application
Table 21. Global Key Players of IVD Infectious Diseases, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IVD Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2018-2023)
Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2024-2029)
Table 27. Global IVD Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global IVD Infectious Diseases Revenue Share by Application (2018-2023)
Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global IVD Infectious Diseases Revenue Share by Application (2024-2029)
Table 31. North America IVD Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America IVD Infectious Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America IVD Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America IVD Infectious Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America IVD Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America IVD Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America IVD Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe IVD Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe IVD Infectious Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe IVD Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe IVD Infectious Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe IVD Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe IVD Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe IVD Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 45. China IVD Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 46. China IVD Infectious Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 47. China IVD Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 48. China IVD Infectious Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia IVD Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia IVD Infectious Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia IVD Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia IVD Infectious Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia IVD Infectious Diseases Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia IVD Infectious Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia IVD Infectious Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America IVD Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD IVD Infectious Diseases Product
Table 66. BD Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 67. BD Recent Developments
Table 68. BioMerieux Company Details
Table 69. BioMerieux Business Overview
Table 70. BioMerieux IVD Infectious Diseases Product
Table 71. BioMerieux Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 72. BioMerieux Recent Developments
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott IVD Infectious Diseases Product
Table 76. Abbott Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 77. Abbott Recent Developments
Table 78. Quidel Company Details
Table 79. Quidel Business Overview
Table 80. Quidel IVD Infectious Diseases Product
Table 81. Quidel Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 82. Quidel Recent Developments
Table 83. Gen-Probe Company Details
Table 84. Gen-Probe Business Overview
Table 85. Gen-Probe IVD Infectious Diseases Product
Table 86. Gen-Probe Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 87. Gen-Probe Recent Developments
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott IVD Infectious Diseases Product
Table 91. Abbott Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 92. Abbott Recent Developments
Table 93. Danaher Company Details
Table 94. Danaher Business Overview
Table 95. Danaher IVD Infectious Diseases Product
Table 96. Danaher Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 97. Danaher Recent Developments
Table 98. Sysmex Company Details
Table 99. Sysmex Business Overview
Table 100. Sysmex IVD Infectious Diseases Product
Table 101. Sysmex Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 102. Sysmex Recent Developments
Table 103. Orasure Company Details
Table 104. Orasure Business Overview
Table 105. Orasure IVD Infectious Diseases Product
Table 106. Orasure Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 107. Orasure Recent Developments
Table 108. Hologic Company Details
Table 109. Hologic Business Overview
Table 110. Hologic IVD Infectious Diseases Product
Table 111. Hologic Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 112. Hologic Recent Developments
Table 113. Cepheid Company Details
Table 114. Cepheid Business Overview
Table 115. Cepheid IVD Infectious Diseases Product
Table 116. Cepheid Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 117. Cepheid Recent Developments
Table 118. Qiagen Company Details
Table 119. Qiagen Business Overview
Table 120. Qiagen IVD Infectious Diseases Product
Table 121. Qiagen Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 122. Qiagen Recent Developments
Table 123. Roche Diagnostics Company Details
Table 124. Roche Diagnostics Business Overview
Table 125. Roche Diagnostics IVD Infectious Diseases Product
Table 126. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 127. Roche Diagnostics Recent Developments
Table 128. Siemens Healthcare Company Details
Table 129. Siemens Healthcare Business Overview
Table 130. Siemens Healthcare IVD Infectious Diseases Product
Table 131. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 132. Siemens Healthcare Recent Developments
Table 133. Bio-Rad Laboratories Company Details
Table 134. Bio-Rad Laboratories Business Overview
Table 135. Bio-Rad Laboratories IVD Infectious Diseases Product
Table 136. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2018-2023) & (US$ Million)
Table 137. Bio-Rad Laboratories Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global IVD Infectious Diseases Market Share by Type: 2022 VS 2029
Figure 3. Immunochemistry Features
Figure 4. Molecular Diagnostics Features
Figure 5. Global IVD Infectious Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global IVD Infectious Diseases Market Share by Application: 2022 VS 2029
Figure 7. Clinical Laboratories Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. IVD Infectious Diseases Report Years Considered
Figure 10. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global IVD Infectious Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global IVD Infectious Diseases Market Share by Region: 2022 VS 2029
Figure 13. Global IVD Infectious Diseases Market Share by Players in 2022
Figure 14. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2022
Figure 16. North America IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America IVD Infectious Diseases Market Share by Type (2018-2029)
Figure 18. North America IVD Infectious Diseases Market Share by Application (2018-2029)
Figure 19. North America IVD Infectious Diseases Market Share by Country (2018-2029)
Figure 20. United States IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe IVD Infectious Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe IVD Infectious Diseases Market Share by Type (2018-2029)
Figure 24. Europe IVD Infectious Diseases Market Share by Application (2018-2029)
Figure 25. Europe IVD Infectious Diseases Market Share by Country (2018-2029)
Figure 26. Germany IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China IVD Infectious Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China IVD Infectious Diseases Market Share by Type (2018-2029)
Figure 34. China IVD Infectious Diseases Market Share by Application (2018-2029)
Figure 35. Asia IVD Infectious Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia IVD Infectious Diseases Market Share by Type (2018-2029)
Figure 37. Asia IVD Infectious Diseases Market Share by Application (2018-2029)
Figure 38. Asia IVD Infectious Diseases Market Share by Region (2018-2029)
Figure 39. Japan IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America IVD Infectious Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America IVD Infectious Diseases Market Share by Country (2018-2029)
Figure 49. Brazil IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries IVD Infectious Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. BD Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 56. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 57. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 58. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 59. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 60. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 61. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 62. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 63. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 64. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 65. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 66. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 67. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 68. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs